Cargando…

Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer

The forkhead transcription factor FOXK2 has recently been implicated in cancer cell proliferation and survival, but a role in cancer chemotherapeutic drug resistance has hitherto not been explored. Here we demonstrate that FOXK2 has a central role in mediating the cytotoxic drug response in breast c...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Moraes, G Nestal, Khongkow, P, Gong, C, Yao, S, Gomes, A R, Ji, Z, Kandola, N, Delbue, D, Man, E P S, Khoo, U S, Sharrocks, A D, Lam, E W-F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767938/ https://www.ncbi.nlm.nih.gov/pubmed/26344694 http://dx.doi.org/10.1038/oncsis.2015.26

Ejemplares similares

The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
por: Monteiro, Lara J., et al.
Publicado: (2012)

Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
por: Zhao, Fung, et al.
Publicado: (2014)

OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance
por: Karunarathna, U, et al.
Publicado: (2016)

Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells
por: Kongsema, Mesayamas, et al.
Publicado: (2019)

SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells
por: Nestal de Moraes, Gabriela, et al.
Publicado: (2018)

Functional interactions between the Forkhead transcription factor FOXK1 and the MADS-box protein SRF
por: Freddie, Cecilie T., et al.
Publicado: (2007)

Alteration of Forkhead Box O (Foxo4) Acetylation Mediates Apoptosis of Podocytes in Diabetes Mellitus
por: Chuang, Peter Y., et al.
Publicado: (2011)

FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
por: Khongkow, Pasarat, et al.
Publicado: (2013)

Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
por: Khongkow, P, et al.
Publicado: (2016)

Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics
por: Tabnak, Peyman, et al.
Publicado: (2023)

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety
por: Baldini, E, et al.
Publicado: (2004)

Role of Forkhead Box Protein O1 (FoxO1) in Stroke: A Literature Review
por: Guo, Sichao, et al.
Publicado: (2022)

Forkhead Box Transcription Factors in Cancer Initiation, Progression and Chemotherapeutic Drug Response
por: Lam, Eric W.-F., et al.
Publicado: (2014)

Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer
por: Han, Gwan Hee, et al.
Publicado: (2019)

Forkhead box O (FOXO) 3 modulates hypoxia-induced autophagy through AMPK signalling pathway in cardiomyocytes
por: Chi, Yunpeng, et al.
Publicado: (2016)

Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
por: Kim, Tae-Hwan, et al.
Publicado: (2009)

Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
por: Gomes, Ana R., et al.
Publicado: (2013)

The crystal structure of human forkhead box N1 in complex with DNA reveals the structural basis for forkhead box family specificity
por: Newman, Joseph A., et al.
Publicado: (2020)

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis
por: Zou, Yiyu, et al.
Publicado: (2008)

Forkhead box protein O1 (FoxO1) /SERPINB1 ameliorates ROS production in diabetic nephropathy
por: Liang, Xiaoya, et al.
Publicado: (2020)

Cross-Talking Pathways of Forkhead Box O1 (FOXO1) Are Involved in the Pathogenesis of Alzheimer's Disease and Huntington's Disease
por: Liu, Liyang, et al.
Publicado: (2022)

Research progress on the forkhead box C1
por: Wang, Jinhua, et al.
Publicado: (2017)

The Dominant Role of Forkhead Box Proteins in Cancer
por: Bach, Duc-Hiep, et al.
Publicado: (2018)

Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis
por: Pereira, Leonn Mendes Soares, et al.
Publicado: (2017)

Bidirectional regulation of osteogenic differentiation by the FOXO subfamily of Forkhead transcription factors in mammalian MSCs
por: Chen, Duanjing, et al.
Publicado: (2018)

A phase II trial of paclitaxel and epirubicin in advanced breast cancer
por: Rischin, D, et al.
Publicado: (2000)

Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
por: Nestal de Moraes, Gabriela, et al.
Publicado: (2016)

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study
por: Frasci, G, et al.
Publicado: (2006)

Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo
por: Ananda Sadagopan, Suresh Kumar, et al.
Publicado: (2015)

Differential Control of iNKT Cell Effector Lineage Differentiation by the Forkhead Box Protein O1 (Foxo1) Transcription Factor
por: Tao, Huishan, et al.
Publicado: (2019)

Effect of Sleeve Gastrectomy on Glycometabolism via Forkhead Box O1 (FoxO1)/Lipocalin-2 (LCN2) Pathway
por: Liu, Zhi, et al.
Publicado: (2020)

Signaling Network of Forkhead Family of Transcription Factors (FOXO) in Dietary Restriction
por: Jiang, Yizhou, et al.
Publicado: (2019)

The Role of Forkhead Box Proteins in Acute Myeloid Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2019)

The Emerging Roles of Forkhead Box (FOX) Proteins in Osteosarcoma
por: Zhang, Wentao, et al.
Publicado: (2017)

Forkhead Box S1 Inhibits the Progression of Hepatocellular Carcinoma
por: Lei, Dengliang, et al.
Publicado: (2020)

The Role of Forkhead Box Family in Bone Metabolism and Diseases
por: Xu, Jianxiang, et al.
Publicado: (2022)

Endometrial Cancer in Aspect of Forkhead Box Protein Contribution
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2022)

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
por: Gennari, A, et al.
Publicado: (2004)

RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A)
por: Roßwag, Sven, et al.
Publicado: (2020)

Forkhead Domains of FOXO Transcription Factors Differ in both Overall Conformation and Dynamics
por: Psenakova, Katarina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ebq15pbgkhuf5cmgqvo8e4c5m